You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 1, 2026

Drug Sales Trends for CYANOCOBALAM


✉ Email this page to a colleague

« Back to Dashboard


Payment Methods and Pharmacy Types for CYANOCOBALAM (2015)

Revenues by Pharmacy Type

Pharmacy Type Revenues
MAIL-ORDER $6,584,258
INSIDE ANOTHER STORE $19,309,364
[disabled in preview] $73,425,578
This preview shows a limited data set
Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Pharmacy Type Units
MAIL-ORDER 386,333
INSIDE ANOTHER STORE 851,077
[disabled in preview] 2,848,149
This preview shows a limited data set
Subscribe for full access, or try a Trial

Revenues by Payment Method

Payment Method Revenues
MEDICAID $4,574,329
MEDICARE $1,171,681
[disabled in preview] $93,631,211
This preview shows a limited data set
Subscribe for full access, or try a Trial
Drug Sales Revenue Trends for CYANOCOBALAM
Drug Units Sold Trends for CYANOCOBALAM

Market Analysis and Sales Projections for Cyanocobalamin

Last updated: February 14, 2026


What is Cyanocobalamin?

Cyanocobalamin is a synthetic form of vitamin B12 used primarily to treat or prevent vitamin B12 deficiency. It is available both as an injectable and oral supplement. The compound is included in multiple over-the-counter (OTC) and prescription products worldwide.

Global Market Size

The global vitamin B12 market was valued at approximately USD 750 million in 2022. Cyanocobalamin represents an estimated 70-80% of this market due to its widespread acceptance as a non-folate B12 form, especially in North America, Europe, and Asia-Pacific.

Key Drivers

  • Rising prevalence of vitamin B12 deficiency related to vegan diets, aging, and gastrointestinal disorders.
  • Expanded use in anemia treatment.
  • Growing awareness of B12's role in neurological functions and energy metabolism.
  • Increased adoption of OTC supplements for preventive health.

Market Segments

Segment Share (2022) Description
Prescription (Rx) products 60% Used mainly for diagnosed deficiency; includes injectable forms
Over-the-counter (OTC) supplements 40% Oral tablets, sublingual formulations; larger consumer base

Regional Outlook

Region Market Share (2022) Key Factors
North America 45% High healthcare awareness, aging population
Europe 25% Strict supplement regulations, widespread OTC use
Asia-Pacific 20% Growing healthcare infrastructure, increasing health awareness
Rest of World 10% Emerging markets, rising demand for nutritional supplements

Competitive Landscape

Major suppliers include Pfizer, Novartis, Teva, and local generic manufacturers. These companies produce both branded and generic cyanocobalamin products, with generics dominating the market due to lower costs.

Sales Projections (2023-2028)

Year Estimated Market Value (USD millions) Growth Rate (CAGR) Commentary
2023 800 Continued demand driven by aging population and diagnosis rates
2024 880 10% Expansion into new geographic markets
2025 968 10% Increased OTC sales; new formulations gaining popularity
2026 1,065 10% Rising prevalence of vegan and vegetarian diets
2027 1,172 10% Greater integration into wellness and preventive health programs
2028 1,289 10% Patent expirations lead to further generic proliferation

Market Opportunities and Risks

Opportunities:

  • Launch of higher-dose formulations for deficiency correction.
  • Expansion into emerging markets.
  • Development of innovative delivery mechanisms, e.g., nasal sprays or sublingual films.

Risks:

  • Regulatory challenges, especially regarding supplement health claims.
  • Competition from alternative B12 forms such as methylcobalamin and hydroxocobalamin.
  • Price erosion due to increasing generic options.

Key Takeaways

  • Cyanocobalamin maintains dominance due to cost-effectiveness and established safety profile.
  • The market is expected to grow at a CAGR of approximately 10% through 2028.
  • Asia-Pacific and emerging markets present significant growth opportunities.
  • Increased consumer interest in preventive health sustains OTC segment growth.

FAQs

1. What are the primary uses of cyanocobalamin?
Treatment of vitamin B12 deficiency, anemia, neurological disorders, and as a supplement to improve energy levels.

2. How does cyanocobalamin compare to other forms of B12?
It is the most stable and cost-effective form, with widespread prescription and OTC use. Methylcobalamin and hydroxocobalamin are also used but are generally more expensive.

3. What are the main markets for cyanocobalamin?
North America, Europe, and Asia-Pacific lead the market, driven by aging populations and increasing health awareness.

4. Which companies dominate the cyanocobalamin market?
Pfizer, Novartis, and Teva hold significant shares, primarily through generics and branded products.

5. What future innovations could influence the market?
New delivery systems and formulations, as well as expanding use in wellness and preventive medicine, could induce further growth.


References

  1. Statista. (2022). Global vitamin B12 market size and forecast.
  2. MarketsandMarkets. (2022). Vitamin B12 market report.
  3. Industry reports and company disclosures.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.